Rheumatology international
-
Case Reports Clinical Trial
The effect of infliximab on extraintestinal manifestations of Crohn's disease.
The purpose of this open pilot study was to assess prospectively the effect of infliximab on extraintestinal manifestations in patients with active Crohn's disease refractory to conventional treatment. ⋯ These preliminary results are encouraging and suggest a promising role of infliximab in the treatment of extraintestinal symptoms of Crohn's disease.